Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 122

Similar articles for PubMed (Select 22116998)

1.

Interstitial lung disease following certolizumab pegol.

Pearce F, Johnson SR, Courtney P.

Rheumatology (Oxford). 2012 Mar;51(3):578-80. doi: 10.1093/rheumatology/ker309. Epub 2011 Nov 23. No abstract available.

2.

Severe interstitial lung disease following treatment with certolizumab pegol: a case report.

Lager J, Hilberg O, L√łkke A, Bendstrup E.

Eur Respir Rev. 2013 Sep 1;22(129):414-6. doi: 10.1183/09059180.00002013. No abstract available.

3.

A case of certolizumab-induced interstitial lung disease in a patient with rheumatoid arthritis.

Glaspole IN, Hoy RF, Ryan PF.

Rheumatology (Oxford). 2013 Dec;52(12):2302-4. doi: 10.1093/rheumatology/ket175. Epub 2013 May 9. No abstract available.

PMID:
23661426
4.

Comment on: A case of certolizumab-induced interstitial lung disease in a patient with rheumatoid arthritis.

Savage EM, Millar AM, Taggart AJ.

Rheumatology (Oxford). 2014 Jun;53(6):1154-5. doi: 10.1093/rheumatology/keu142. Epub 2014 Mar 27. No abstract available.

PMID:
24681838
5.

Comment on: A case of certolizumab-induced interstitial lung disease in a patient with rheumatoid arthritis: reply.

Glaspole I, Hoy R, Ryan P.

Rheumatology (Oxford). 2014 Jun;53(6):1155. doi: 10.1093/rheumatology/keu144. Epub 2014 Mar 27. No abstract available.

PMID:
24681841
6.

Fatal fibrosing alveolitis with certolizumab.

Millar A, McKew J, Taggart A.

Rheumatology (Oxford). 2012 May;51(5):953-5. doi: 10.1093/rheumatology/ker452. Epub 2012 Feb 10. No abstract available.

7.

Certolizumab for rheumatoid arthritis.

Markatseli TE, Papagoras C, Nikoli A, Voulgari PV, Drosos AA.

Clin Exp Rheumatol. 2014 May-Jun;32(3):415-23. Epub 2014 Jan 20. Review.

PMID:
24447441
8.

Long-term efficacy and safety of certolizumab pegol in Japanese rheumatoid arthritis patients who could not receive methotrexate: 52-week results from an open-label extension of the HIKARI study.

Tanaka Y, Yamamoto K, Takeuchi T, Yamanaka H, Ishiguro N, Eguchi K, Watanabe A, Origasa H, Shoji T, Miyasaka N, Koike T.

Mod Rheumatol. 2014 Sep;24(5):725-33. doi: 10.3109/14397595.2013.865822. Epub 2013 Dec 29.

PMID:
24372225
9.

How FABulous is PEGgy? Certoliziumab pegol from the bench to the patients.

Aletaha D.

BioDrugs. 2014 Apr;28 Suppl 1:S3-4. doi: 10.1007/s40259-013-0067-9. No abstract available.

PMID:
24687233
10.

[Certolizumab pegol--new possibilities in the treatment of Crohn's disease].

Lazebnik LB, Kniazev OV.

Eksp Klin Gastroenterol. 2012;(3):100-5. Review. Russian. No abstract available.

PMID:
22830233
11.

Pegylation of biological molecules and potential benefits: pharmacological properties of certolizumab pegol.

Pasut G.

BioDrugs. 2014 Apr;28 Suppl 1:S15-23. doi: 10.1007/s40259-013-0064-z. Review.

PMID:
24687235
12.

The clinical efficacy and safety of certolizumab pegol in rheumatoid arthritis.

Fleischmann R.

Expert Opin Biol Ther. 2010 May;10(5):773-86. doi: 10.1517/14712591003724688. Review.

PMID:
20230188
13.

Drug-induced erythema nodosum after the administration of certolizumab in Crohn's disease.

Biedermann L, Kerl K, Rogler G, Hofbauer GF.

Inflamm Bowel Dis. 2013 Jan;19(1):E4-6. doi: 10.1002/ibd.21942. No abstract available.

PMID:
22127817
14.

Blaschkitis under certolizumab for rheumatoid arthritis.

Couderc M, Soubrier M.

Joint Bone Spine. 2014 Jul;81(4):372-3. doi: 10.1016/j.jbspin.2013.12.004. Epub 2014 Jan 16. No abstract available.

PMID:
24439961
15.
16.

Certolizumab pegol (Cimzia) and ustekinumab (Stelara) for psoriatic arthritis.

[No authors listed]

Med Lett Drugs Ther. 2014 Feb 3;56(1435):10-2. No abstract available.

PMID:
24662976
17.

Certolizumab pegol: a review of its use in the management of rheumatoid arthritis.

Deeks ED.

Drugs. 2013 Jan;73(1):75-97. doi: 10.1007/s40265-013-0009-3. Review.

PMID:
23338540
18.

Biological agents in monotherapy for the treatment of rheumatoid arthritis.

Gabay C, Hasler P, Kyburz D, So A, Villiger P, von Kempis J, Walker U.

Swiss Med Wkly. 2014 Apr 10;144:w13950. doi: 10.4414/smw.2014.13950. eCollection 2014. Review.

19.
20.

Vaccine responses in patients with rheumatoid arthritis treated with certolizumab pegol: results from a single-blind randomized phase IV trial.

Kivitz AJ, Schechtman J, Texter M, Fichtner A, de Longueville M, Chartash EK.

J Rheumatol. 2014 Apr;41(4):648-57. doi: 10.3899/jrheum.130945. Epub 2014 Mar 1.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk